Shopping Cart 0
Cart Subtotal
USD 0

Peripherally Inserted Central Catheter (PICC)-Medical Devices Pipeline Assessment, 2017

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2500

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 5000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 7500
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Peripherally Inserted Central Catheter (PICC)-Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, "Peripherally Inserted Central Catheter (PICC)-Medical Devices Pipeline Assessment, 2017" provides an overview of Peripherally Inserted Central Catheter (PICC) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and the number of trials for the key Peripherally Inserted Central Catheter (PICC) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Peripherally Inserted Central Catheter (PICC) under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Peripherally Inserted Central Catheter (PICC) and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons to Buy

The report enables you to-

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Peripherally Inserted Central Catheter (PICC) under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product's current stage of development, territory and estimated launch date

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 4

2 Introduction 5

2.1 Peripherally Inserted Central Catheter (PICC) Overview 5

3 Products under Development 6

3.1 Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Stage of Development 6

3.2 Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Territory 7

3.3 Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Regulatory Path 8

3.4 Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Estimated Approval Date 9

4 Peripherally Inserted Central Catheter (PICC)-Pipeline Products under Development by Companies 10

4.1 Peripherally Inserted Central Catheter (PICC) Companies-Pipeline Products by Stage of Development 10

4.2 Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Stage of Development 11

5 Peripherally Inserted Central Catheter (PICC) Companies and Product Overview 12

5.1 AngioDynamics Inc Company Overview 12

5.1.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 12

5.2 C. R. Bard Inc Company Overview 14

5.2.1 C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 14

5.3 University of Texas Health Science Center at Houston Company Overview 17

5.3.1 University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview 17

6 Peripherally Inserted Central Catheter (PICC)- Recent Developments 18

6.1 Mar 01, 2017: ICU Medical Announces Fourth Quarter and Fiscal Year 2016 Results 18

6.2 Feb 23, 2017: Teleflex Announces Benson Smith to Retire as Chief Executive Officer at End of 2017; Liam Kelly to Succeed Smith as Chief Executive Officer 18

6.3 Feb 23, 2017: Teleflex Reports Fourth Quarter and Full Year 2016 Results; Provides 2017 Guidance 19

6.4 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 21

6.5 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 23

6.6 Jan 26, 2017: Bard Announces Fourth Quarter Results 24

6.7 Jan 06, 2017: AngioDynamics Reports Fiscal 2017 Second Quarter Results 25

6.8 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 26

6.9 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 29

6.10 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 30

6.11 Nov 14, 2016: AngioDynamics Prices Public Offering of Shares for USD32 Million 30

6.12 Nov 09, 2016: ICU Medical Announces Third Quarter 2016 Results 31

6.13 Nov 09, 2016: AngioDynamics Announces Addition of New Board Members 31

6.14 Oct 27, 2016: Teleflex Reports Third Quarter 2016 Results 32

6.15 Oct 25, 2016: Bard Announces Third Quarter Results 34

6.16 Oct 17, 2016: Teleflex Receives FDA Clearance for the Arrow Midline with Chlorag+ard Technology 35

6.17 Oct 05, 2016: AngioDynamics Reports Fiscal 2017 First Quarter Results 35

6.18 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 36

6.19 Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China 37

6.20 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 38

6.21 Aug 08, 2016: ICU Medical Announces Second Quarter 2016 Results 40

6.22 Jul 28, 2016: Teleflex Reports Second Quarter 2016 Results 41

6.23 Jul 26, 2016: Bard Announces Second Quarter Results 43

6.24 Jul 25, 2016: AngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer 43

6.25 Jul 13, 2016: AngioDynamics Reports Fiscal 2016 Fourth Quarter and Full Year Results 44

6.26 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 45

6.27 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 46

6.28 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 46

6.29 May 11, 2016: Teleflex Raises USD400 Million in Public Offering of 4.875% Notes Due 2026 49

6.30 May 10, 2016: ICU Medical Announces First Quarter 2016 Results 50

6.31 May 03, 2016: Cook Medical Issues Global, Voluntary Recall of Catheters with Beacon Tip Technology 50

6.32 Apr 21, 2016: Eos Biosciences recruited Thomas Plotts to join the company as its Chief Financial Officer 52

6.33 Apr 07, 2016: AngioDynamics Reports Fiscal 2016 Third Quarter Results 52

7 Appendix 54

7.1 Methodology 54

7.2 About GlobalData 57

7.3 Contact Us 57

7.4 Disclaimer 57


List Of Figure

1.2 List of Figures

Figure 1: Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Stage of Development 6

Figure 2: Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Territory 7

Figure 3: Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Regulatory Path 8

Figure 4: Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Estimated Approval Date 9


List Of Table

1.1 List of Tables

Table 1: Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Stage of Development 6

Table 2: Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Territory 7

Table 3: Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Regulatory Path 8

Table 4: Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Estimated Approval Date 9

Table 5: Peripherally Inserted Central Catheter (PICC) Companies-Pipeline Products by Stage of Development 10

Table 6: Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Stage of Development 11

Table 7: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 12

Table 8: BioFlo PICC Line Extension-Product Status 12

Table 9: BioFlo PICC Line Extension-Product Description 12

Table 10: Next Generation BioFlo PICC-Product Status 13

Table 11: Next Generation BioFlo PICC-Product Description 13

Table 12: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 14

Table 13: Anti-Thrombotic PICCs-Product Status 14

Table 14: Anti-Thrombotic PICCs-Product Description 15

Table 15: Antimicrobial PICC-Product Status 15

Table 16: Antimicrobial PICC-Product Description 15

Table 17: COVERT PowerPICC-Product Status 16

Table 18: COVERT PowerPICC-Product Description 16

Table 19: Internal Jugular Placement Catheter-Product Status 16

Table 20: Internal Jugular Placement Catheter-Product Description 16

Table 21: University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview 17

Table 22: Automated Catheter Insertion System-Product Status 17

Table 23: Automated Catheter Insertion System-Product Description 17

Table 24: Glossary 56

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

AngioDynamics Inc, C. R. Bard Inc, University of Texas Health Science Center at Houston

Peripherally Inserted Central Catheter (PICC)-Medical Devices Pipeline Assessment, 2017

Summary

GlobalData's Medical Devices sector report, "Peripherally Inserted Central Catheter (PICC)-Medical Devices Pipeline Assessment, 2017" provides an overview of Peripherally Inserted Central Catheter (PICC) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and the number of trials for the key Peripherally Inserted Central Catheter (PICC) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Peripherally Inserted Central Catheter (PICC) under development

The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

The report reviews the major players involved in the development of Peripherally Inserted Central Catheter (PICC) and list all their pipeline projects

The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

The report provides key clinical trial data of ongoing trials specific to pipeline products

Recent developments in the segment / industry

Reasons to Buy

The report enables you to-

Formulate significant competitor information, analysis, and insights to improve R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of Peripherally Inserted Central Catheter (PICC) under development

Develop market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

In-depth analysis of the product's current stage of development, territory and estimated launch date

READ MORE

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 4

1.2 List of Figures 4

2 Introduction 5

2.1 Peripherally Inserted Central Catheter (PICC) Overview 5

3 Products under Development 6

3.1 Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Stage of Development 6

3.2 Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Territory 7

3.3 Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Regulatory Path 8

3.4 Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Estimated Approval Date 9

4 Peripherally Inserted Central Catheter (PICC)-Pipeline Products under Development by Companies 10

4.1 Peripherally Inserted Central Catheter (PICC) Companies-Pipeline Products by Stage of Development 10

4.2 Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Stage of Development 11

5 Peripherally Inserted Central Catheter (PICC) Companies and Product Overview 12

5.1 AngioDynamics Inc Company Overview 12

5.1.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 12

5.2 C. R. Bard Inc Company Overview 14

5.2.1 C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 14

5.3 University of Texas Health Science Center at Houston Company Overview 17

5.3.1 University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview 17

6 Peripherally Inserted Central Catheter (PICC)- Recent Developments 18

6.1 Mar 01, 2017: ICU Medical Announces Fourth Quarter and Fiscal Year 2016 Results 18

6.2 Feb 23, 2017: Teleflex Announces Benson Smith to Retire as Chief Executive Officer at End of 2017; Liam Kelly to Succeed Smith as Chief Executive Officer 18

6.3 Feb 23, 2017: Teleflex Reports Fourth Quarter and Full Year 2016 Results; Provides 2017 Guidance 19

6.4 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 21

6.5 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 23

6.6 Jan 26, 2017: Bard Announces Fourth Quarter Results 24

6.7 Jan 06, 2017: AngioDynamics Reports Fiscal 2017 Second Quarter Results 25

6.8 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 26

6.9 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 29

6.10 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 30

6.11 Nov 14, 2016: AngioDynamics Prices Public Offering of Shares for USD32 Million 30

6.12 Nov 09, 2016: ICU Medical Announces Third Quarter 2016 Results 31

6.13 Nov 09, 2016: AngioDynamics Announces Addition of New Board Members 31

6.14 Oct 27, 2016: Teleflex Reports Third Quarter 2016 Results 32

6.15 Oct 25, 2016: Bard Announces Third Quarter Results 34

6.16 Oct 17, 2016: Teleflex Receives FDA Clearance for the Arrow Midline with Chlorag+ard Technology 35

6.17 Oct 05, 2016: AngioDynamics Reports Fiscal 2017 First Quarter Results 35

6.18 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 36

6.19 Aug 31, 2016: Cook Medical Names Jean-Marc Creissel Vice President of Operations in Greater China 37

6.20 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 38

6.21 Aug 08, 2016: ICU Medical Announces Second Quarter 2016 Results 40

6.22 Jul 28, 2016: Teleflex Reports Second Quarter 2016 Results 41

6.23 Jul 26, 2016: Bard Announces Second Quarter Results 43

6.24 Jul 25, 2016: AngioDynamics Appoints Michael C. Greiner as New Chief Financial Officer 43

6.25 Jul 13, 2016: AngioDynamics Reports Fiscal 2016 Fourth Quarter and Full Year Results 44

6.26 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic 45

6.27 Jun 06, 2016: Medtronic Outlines Future Growth Vision at Investor Day 46

6.28 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 46

6.29 May 11, 2016: Teleflex Raises USD400 Million in Public Offering of 4.875% Notes Due 2026 49

6.30 May 10, 2016: ICU Medical Announces First Quarter 2016 Results 50

6.31 May 03, 2016: Cook Medical Issues Global, Voluntary Recall of Catheters with Beacon Tip Technology 50

6.32 Apr 21, 2016: Eos Biosciences recruited Thomas Plotts to join the company as its Chief Financial Officer 52

6.33 Apr 07, 2016: AngioDynamics Reports Fiscal 2016 Third Quarter Results 52

7 Appendix 54

7.1 Methodology 54

7.2 About GlobalData 57

7.3 Contact Us 57

7.4 Disclaimer 57


List Of Figure

1.2 List of Figures

Figure 1: Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Stage of Development 6

Figure 2: Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Territory 7

Figure 3: Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Regulatory Path 8

Figure 4: Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Estimated Approval Date 9


List Of Table

1.1 List of Tables

Table 1: Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Stage of Development 6

Table 2: Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Territory 7

Table 3: Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Regulatory Path 8

Table 4: Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Estimated Approval Date 9

Table 5: Peripherally Inserted Central Catheter (PICC) Companies-Pipeline Products by Stage of Development 10

Table 6: Peripherally Inserted Central Catheter (PICC)-Pipeline Products by Stage of Development 11

Table 7: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 12

Table 8: BioFlo PICC Line Extension-Product Status 12

Table 9: BioFlo PICC Line Extension-Product Description 12

Table 10: Next Generation BioFlo PICC-Product Status 13

Table 11: Next Generation BioFlo PICC-Product Description 13

Table 12: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 14

Table 13: Anti-Thrombotic PICCs-Product Status 14

Table 14: Anti-Thrombotic PICCs-Product Description 15

Table 15: Antimicrobial PICC-Product Status 15

Table 16: Antimicrobial PICC-Product Description 15

Table 17: COVERT PowerPICC-Product Status 16

Table 18: COVERT PowerPICC-Product Description 16

Table 19: Internal Jugular Placement Catheter-Product Status 16

Table 20: Internal Jugular Placement Catheter-Product Description 16

Table 21: University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview 17

Table 22: Automated Catheter Insertion System-Product Status 17

Table 23: Automated Catheter Insertion System-Product Description 17

Table 24: Glossary 56

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

AngioDynamics Inc, C. R. Bard Inc, University of Texas Health Science Center at Houston

chat_bubbleLet's Chat